Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

8.22
+0.02000.24%
Volume:1.33M
Turnover:11.02M
Market Cap:1.13B
PE:-2.15
High:8.51
Open:8.26
Low:8.11
Close:8.20
Loading ...

VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

Zacks
·
10 Jan

Vir Biotechnology Reports Promising Trial Results for Cancer Therapies

TipRanks
·
09 Jan

Vir Biotechnology Is Maintained at Neutral by JP Morgan

Dow Jones
·
09 Jan

Morgan Stanley Upgrades Vir Biotechnology to Overweight From Equalweight, Adjusts Price Target to $20 From $10

MT Newswires Live
·
09 Jan

Vir Biotechnology (VIR) Gets a Buy from Barclays

TIPRANKS
·
09 Jan

U.S. RESEARCH ROUNDUP-Accolade, Costco Wholesale, RH

Reuters
·
09 Jan

Vir Biotechnology Inc : JP Morgan Raises Target Price to $14 From $10

THOMSON REUTERS
·
09 Jan

Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com

Dow Jones
·
09 Jan

Vir Biotechnology Up Over 65%, on Pace for Largest Percent Increase Since January 2021 -- Data Talk

Dow Jones
·
08 Jan

Vir Biotech Shares Rise on Positive Data for Cancer Treatments

Dow Jones
·
08 Jan

Vir Biotechnology Shares up 55.8% on Positive Data From Early-Stage Trials for Tumor Treatments

THOMSON REUTERS
·
08 Jan

BUZZ-Vir jumps on positive data from early-stage trials for tumor treatments

Reuters
·
08 Jan

BRIEF-Vir Biotechnology Announces Encouraging Safety And Efficacy Data In Ongoing Dose Escalation Trials For Dual Masked T-Cell Engagers VIR-5818 In Solid Tumors And VIR-5500 In mCRPC

Reuters
·
08 Jan

Vir Biotechnology presents safety, efficacy data in VIR-5818 and VIR-5500 trials

TIPRANKS
·
08 Jan

Vir Biotechnology Shares up 31.7% Premarket After Early-Stage Trial Data for Prostate Cancer Treatment

THOMSON REUTERS
·
08 Jan

Vir Biotechnology Inc - No Dose-Limiting Crs Observed for Vir-5818 or Vir-5500

THOMSON REUTERS
·
08 Jan